Harvard Bioscience Inc (HBIO) — 8-K Filings
All 8-K filings from Harvard Bioscience Inc. Browse 17 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (17)
- 8-K Filing — Dec 17, 2025
-
Harvard Bioscience Files 8-K Report
— Dec 5, 2025 Risk: low
On December 5, 2025, Harvard Bioscience, Inc. filed an 8-K report. The filing indicates "Other Events" as the item information, with no specific details provide -
Harvard Bioscience Faces Delisting Concerns
— Oct 3, 2025 Risk: high
Harvard Bioscience, Inc. filed an 8-K on October 3, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, effective -
Harvard Bioscience Announces Board Changes and Officer Appointments
— Sep 9, 2025 Risk: medium
Harvard Bioscience, Inc. announced on September 5, 2025, a series of significant corporate actions. These include the departure of directors, the election of ne -
Harvard Bioscience Announces Board and Executive Changes
— Aug 13, 2025 Risk: medium
Harvard Bioscience, Inc. announced on August 12, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departu -
Harvard Bioscience Files 8-K on Officer/Director Changes
— Jul 17, 2025 Risk: low
On July 16, 2025, Harvard Bioscience, Inc. filed an 8-K report detailing changes in its board of directors and executive officers. The filing also includes info -
Harvard Bioscience Faces Delisting Concerns
— Jun 23, 2025 Risk: high
Harvard Bioscience, Inc. filed an 8-K on June 23, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and a transf -
Harvard Bioscience Announces Board and Executive Compensation Changes
— Jun 13, 2025 Risk: medium
Harvard Bioscience, Inc. announced on June 10, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure -
Harvard Bioscience Files 8-K on Officer Changes and Shareholder Votes
— Jun 2, 2025 Risk: low
Harvard Bioscience, Inc. filed an 8-K on May 30, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certai -
Harvard Bioscience Files 8-K on Officer/Director Changes
— Apr 16, 2025 Risk: medium
Harvard Bioscience, Inc. filed an 8-K on April 16, 2025, reporting events as of April 10, 2025. The filing pertains to the departure of directors or certain off -
Harvard Bioscience Faces Nasdaq Delisting Notice
— Apr 10, 2025 Risk: high
Harvard Bioscience, Inc. announced on April 10, 2025, that it received a notice from the Nasdaq Stock Market regarding its failure to meet continued listing req -
Harvard Bioscience Files 8-K: Material Agreement, Other Events
— Mar 12, 2025 Risk: medium
On March 10, 2025, Harvard Bioscience, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial s -
Harvard Bioscience Files 8-K on Financials
— Nov 7, 2024 Risk: low
Harvard Bioscience, Inc. filed an 8-K on November 7, 2024, to report on its results of operations and financial condition, as well as to file financial statemen -
Harvard Bioscience Files 8-K on Security Holder Vote
— May 14, 2024 Risk: low
On May 14, 2024, Harvard Bioscience, Inc. filed an 8-K report indicating that it submitted matters to a vote of its security holders. The filing does not specif -
Harvard Bioscience Files 8-K with Material Agreement
— Apr 3, 2024 Risk: medium
On March 28, 2024, Harvard Bioscience, Inc. entered into a Material Definitive Agreement. The filing also includes other events and financial statements and exh -
Harvard Bioscience Appoints New CEO, Jeffrey S. Glass
— Mar 26, 2024 Risk: medium
Harvard Bioscience, Inc. announced on March 21, 2024, the appointment of Jeffrey S. Glass as its new Chief Executive Officer and a member of the Board of Direct -
HARVARD BIOSCIENCE Files 8-K for Reg FD Disclosure, Financials
— Jan 5, 2024
HARVARD BIOSCIENCE, INC. filed an 8-K on January 5, 2024, to disclose that it is making a Regulation FD disclosure, which means it's sharing important, non-publ
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX